Abstract:Abstract Exosomes, lipid bilayer-enclosed small cellular vesicles, are actively secreted by various cells and play crucial roles in intercellular communication. These nanosized vesicles transport internalized proteins, mRNA, miRNA, and other bioactive molecules. Recent findings have provided compelling evidence that exosomes derived from stem cells hold great promise as a therapeutic modality for central nervous system disorders. These exosomes exhibit multifaceted properties including antiapoptotic, anti-inflammatory, neurogenic, and vasculogenic effects. Furthermore, exosomes offer several advantages over stem cell therapy, such as high preservation capacity, low immunogenicity, the ability to traverse the blood-brain barrier, and the potential for drug encapsulation. Consequently, researchers have turned their attention to exosomes as a novel therapeutic avenue. Nonetheless, akin to the limitations of stem cell treatment, the limited accumulation of exosomes in the injured brain poses a challenge to their clinical application. To overcome this hurdle, intranasal administration has emerged as a non-invasive and efficacious route for delivering drugs to the central nervous system. By exploiting the olfactory and trigeminal nerve axons, this approach enables the direct transport of therapeutics to the brain while bypassing the blood-brain barrier. Notably, exosomes, owing to their small size, can readily access the nerve pathways using this method. As a result, intranasal administration has gained increasing recognition as an optimal therapeutic strategy for exosomebased treatments. In this comprehensive review, we aim to provide an overview of both basic and clinical research studies investigating the intranasal administration of exosomes for the treatment of central nervous system diseases. Furthermore, we elucidate the underlying therapeutic mechanisms and offer insights into the prospect of this approach.

Exosomes as cell-derivative carriers in the diagnosis and treatment of central nervous system diseases

Exosomal Mirnas in Central Nervous System Diseases: Biomarkers, Pathological Mediators, Protective Factors and Therapeutic Agents.

Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases

Exosomes in Central Nervous System Diseases: A Comprehensive Review of Emerging Research and Clinical Frontiers

Role of Exosomes in Central Nervous System Diseases

The promise of exosome applications in treating central nervous system diseases

Exosomes in the Diagnosis of Neuropsychiatric Diseases: A Review

Exosome-based drug delivery systems for enhanced neurological therapeutics

Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine?

Applications of Extracellular Vesicles in Nervous System Disorders: An Overview of Recent Advances

Extracellular Vesicle-Mediated Cell–Cell Communication in the Nervous System: Focus on Neurological Diseases

Intranasal administration of stem cell-derived exosomes for central nervous system diseases

Exosomes As CNS Drug Delivery Tools and Their Applications

Exosomes, an Unmasked Culprit in Neurodegenerative Diseases

Isolation and usage of exosomes in central nervous system diseases

Unveiling the role of exosomes as cellular messengers in neurodegenerative diseases and their potential therapeutic implications

Nanomaterials-Based Exosomes for the Diagnostics and Drug Deliveries of Central Nervous System Diseases

Exosomes for neurodegenerative diseases: diagnosis and targeted therapy

Exosomes as drug delivery vehicles and biomarkers for neurological and auditory systems

Exosomal noncoding RNAs in central nervous system diseases: biological functions and potential clinical applications